Processa Pharmaceuticals (PCSA) Curent Deferred Tax Liability (2012)

Processa Pharmaceuticals' (PCSA) quarterly Curent Deferred Tax Liability came in at $49310.0 in Q4 2012.

Processa Pharmaceuticals (PCSA) Curent Deferred Tax Liability (2012) Analysis & Trends

Processa Pharmaceuticals (PCSA) has 1 years of Curent Deferred Tax Liability data on file, last reported at $49310.0 in Q4 2012.

Quarterly Curent Deferred Tax Liability changed N/A year-over-year to $49310.0 in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $49310.0 (changed N/A YoY) and the FY2012 annual result came in at $49310.0, changed N/A from the prior year.
Curent Deferred Tax Liability steadied at $49310.0 in Q4 2012.
In the past five years, Curent Deferred Tax Liability ranged from a high of $49310.0 in Q4 2012 to a low of $49310.0 in Q4 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Curent Deferred Tax Liability (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Processa Pharmaceuticals	5.69 Mn	5.69 Mn	-	-

Download Data

Date	Value
Dec 31, 2012	49,310.00
Dec 31, 2012	49,310.00